On March 26, 2026, Henkel announced plans to acquire OLAPLEX in an all-cash transaction valued at approximately $1.4Bn. Under the terms of the agreement, OLAPLEX shareholders are expected to receive $2.06 per share in cash, representing a premium of approximately 55% to OLAPLEX’s closing share price on March 25, 2026 and a premium of approximately 45% to the volume-weighted average price over the prior 30 trading days. The transaction has been unanimously approved by OLAPLEX’s Board of Directors and by Advent International, OLAPLEX’s majority shareholder, and is expected to close in the second half of 2026, subject to customary regulatory approvals and closing conditions. Upon completion, OLAPLEX will delist from the Nasdaq Stock Market and operate as a privately held company within Henkel’s consumer brands portfolio.

The transaction reflects continued consolidation within the global beauty and personal care sector, particularly within premium and science-driven product categories, and a recalibration of how public markets have valued single-brand prestige beauty assets following several years of compressed multiples and uneven trading performance.

Strategic Rationale: Henkel

Henkel is a large consumer goods and industrial company based in Germany, with operations spanning adhesives, home care and beauty products. Within haircare, Henkel maintains an established portfolio of brands, including Schwarzkopf, Joico and Kenra, positioning it as a significant participant within the global market, though one historically weighted toward the professional and mid-market rather than prestige segments.

OLAPLEX addresses that gap directly. Its brand recognition, proprietary bond-building technology and established presence within salon channels complement Henkel’s existing portfolio while expanding reach among prestige consumers — a category in which Henkel has historically lacked a flagship — and provides greater exposure to higher-margin treatment-based products for which pricing power and customer retention exceed mass-market benchmarks.

Integration into Henkel’s global manufacturing, retail relationships and supply chain is also expected to support distribution expansion into geographies that OLAPLEX has not previously prioritized and margin improvement through supply chain consolidation. The all-cash structure reflects Henkel’s enthusiasm for the prestige category, while limiting downside exposure for Henkel shareholders associated with stock-based consideration.

Strategic Rationale: OLAPLEX

OLAPLEX is a U.S.-based prestige haircare company best known for its bond-building technology, which repairs damaged hair at the molecular level. In fiscal year 2025, the company generated approximately €370MM in sales, reflecting continued demand for premium treatment-oriented products despite broader pressures on discretionary consumer spending.

OLAPLEX went public in 2021 at a peak valuation that exceeded $10Bn and has traded materially lower since, weighed down by slowing growth, litigation overhang and shifting consumer trends within prestige beauty. The transaction at $1.4Bn may therefore reflect both the strategic value of the brand to a global consumer goods acquirer and the practical limits of standalone public-company status for mid-cap single-brand prestige assets.

Private ownership should also allow OLAPLEX management to focus on product development, brand positioning and channel optimization, free from the pressures of public market reporting cycles and quarterly earnings expectations. For Advent International, which held its majority position through OLAPLEX’s post-IPO decline, the 45% premium to the 30-day VWAP offers value realization at a level meaningfully above recent trading levels and provides certain liquidity in cash rather than continued exposure to public-market volatility.

Prestige Beauty Market Context

The transaction fits a broader pattern of large consumer goods companies acquiring premium beauty assets with strong consumer loyalty, differentiated intellectual property and established digital engagement, with comparable activity from L’Oréal, Unilever and Procter & Gamble across adjacent segments. As growth within traditional packaged consumer categories moderates, strategic acquirers may increasingly pursue premium beauty assets capable of offering stronger margins, direct consumer engagement and faster growth profiles.

The category is also being reshaped by distribution. Social and influencer-led marketing has compressed the timeline for newer brands to build awareness, but scaling internationally still requires the supply chain and regulatory and retail infrastructure that incumbents control — an asymmetry that may make founder-led prestige brands attractive acquisition targets once they reach meaningful scale and limits their likelihood of remaining independent at the next stage of growth.

Industry Implications

Upon completion, the transaction will reinforce a clear thesis within beauty M&A: strategic acquirers are paying premium multiples for differentiated IP and brand equity, not for scale alone. Brands without proprietary product technology or defensible category positioning may face a more difficult path either as public companies or as acquisition targets.

The deal may also illustrate the diminishing appeal of standalone public-company status for mid-cap consumer brands. OLAPLEX’s trajectory from a $10Bn+ IPO peak to a $1.4Bn take-private may suggest that public markets struggle to underwrite single-brand prestige beauty companies through normal demand cycles, while strategic acquirers that operate with longer time horizons and integration synergies may be better positioned to capture remaining value.

About DelMorgan & Co. (www.delmorganco.com)

With over $300 billion of successful transactions in over 80 countries, DelMorgan‘s Investment Banking professionals have worked on some of the most challenging, most rewarding and highest profile transactions in the U.S. and around the globe. DelMorgan specializes in capital raising and M&A advisor services for companies across all industries and is recognized as one of the leading investment banking practices in California and globally.

Learn more about DelMorgan’s Capabilities, Transactions, and why DelMorgan is ranked as the #1 Investment Bank in Los Angeles and #2 in California by Axial.